NAD Tries To Steer Syntratech From Diabetes Claims, Rx Comparisons
This article was originally published in The Tan Sheet
Executive Summary
Syntratech says claims it made for its Syntra-5 herbal product do not imply it conducted comparisons with Rx drugs, but the firm may risk a run-in with FDA or the Federal Trade Commission with some of its claims
You may also be interested in...
National Advertising Division Conference In Brief
The National Advertising Division, a self-regulatory agency that reviews advertising claims, administered by the Council of Better Business Bureaus, held its annual conference Oct. 4 and 5 in New York City. The event, "What's New in Comparative Advertising, Claim Support and Self-Regulation," covered claim substantiation for all types of products at all levels of government and within NAD
National Advertising Division Conference In Brief
The National Advertising Division, a self-regulatory agency that reviews advertising claims, administered by the Council of Better Business Bureaus, held its annual conference Oct. 4 and 5 in New York City. The event, "What's New in Comparative Advertising, Claim Support and Self-Regulation," covered claim substantiation for all types of products at all levels of government and within NAD
National Advertising Division Conference In Brief
The National Advertising Division, a self-regulatory agency that reviews advertising claims, administered by the Council of Better Business Bureaus, held its annual conference Oct. 4 and 5 in New York City. The event, "What's New in Comparative Advertising, Claim Support and Self-Regulation," covered claim substantiation for all types of products at all levels of government and within NAD